Fetal & Neonatal Care Equipment Market - Forecasts from 2020 to 2025
The global fetal & neonatal care equipment market is estimated to surge at a CAGR of 5.23% from a market value of USD8.661 billion in 2019 to achieve a market value of USD11.760 billion by the end of 2025. Fetal & neonatal care equipment, whether, monitoring, treatment, or diagnostic device, offers care to a newborn or an unborn fetus diagnosed with a medical condition. These equipment comprise phototherapy equipment, incubators, cardiopulmonary monitor, umbilical catheter, pulse oximeter, and many more. The market is projected to grow at a fast pace with the growing preterm birth cases at the global level. The growing incidences of congenital diseases are further augmenting the market demand during the forecast period. The availability of advanced systems due to the growing technological advancements is further providing an impetus in fueling the market growth over the next five years. Additionally, growing fertility tourism demanding state-of-the-art equipment for monitoring fetal and newborn health is further providing an opportunity for the market to propagate during the forecast period. Rising cesarean births is further propelling the market demand in the forecast period. Concerns regarding the increased risk for mothers over 35 years of age to experience complications during pregnancy and delivery are further providing an opportunity for the market to proliferate over the forecast period.
Geographically, North America is projected to hold a significant market share in the forecast period owing to the advanced healthcare facilities for mother and their newborns. Also, the highest health expenditure of the United States is further contributing to surging the market growth in the forecast period. The shift from volume-based care to value-based care is further offering strong market growth prospects in the forecast period. On the other hand, the Asia Pacific region is projected to experience high growth during the forecast period due to rising awareness regarding efficient care during pregnancy and at the time of delivery. Also, significant initiatives for providing efficient healthcare services to the mother and their newborn is further augmenting the market demand in the forecast period.
COVID-19 impact on the fetal & neonatal care equipment market: The novel coronavirus pandemic has affected the global economies. Companies in fetal and neonatal care businesses are trying their level best to monitor the situation closely and are ready to assess any impact on supply and daily operations. Due to lockdown and work-from-home measures companies are working through challenges causing material and capacity issues with some of the suppliers. Hence, the market is projected to experience a slight decline amid COVID-19 due to some level of disruption causing shipment delays to the customers.
The growing fertility tourism will continue to proliferate the market demand during the course of the forecast period.
Fertility treatments, also known as cross border reproductive care (CBRC) are gaining popularity at the global level where people including infertile couples, single, gay, or transgender individuals are seeking effective fertility treatments outside of their home countries. The major reason for the adoption of reproductive treatments abroad includes legal restrictions and the high cost of treatment in their home countries. Also, among other reasons include quality of care, i.e. success rate and long waits, and sociocultural considerations, that play a significant role in choosing fertility treatments abroad. The most common forms of fertility treatments involve in vitro fertilization, intracytoplasmic sperm injection, sperm donation, egg donation, and fertility preservation among others.
Growing infertility among males and females worldwide is one of the major factors driving fertility tourism. In the United States, it has been observed that around 10% of the women that are aged between 15 years of age to 44 years of age are experiencing difficulty in conceiving or staying pregnant. On an international level, it has been estimated that over 8% of the couples are affected by fertility issues. It has further been analyzed that out of all the infertility cases, close to 50% cases are affecting males. Hence, with this, the market is projected to show strong prospects for growth along with a greater demand for reproductive care. Infertility in males is due to specific medical conditions like diabetes, thyroid disorders, genetic disorders, and hormonal imbalances among others. For females, infertility arises due to the adoption of unhealthy living conditions like smoking, active or passive, being obese or overweight, exposure to chemicals, and mental stress among others.
The growing rate of cesarean section is further providing an opportunity for the market to thrive over the forecast period.
It has been noticed on a wide scale that the rate of C-sections is growing at a rapid pace. It has further been observed that the rate of cesarean has exceeded the number of vaginal deliveries in the regions of Southeast Europe, Latin American countries, and China. Even in less-developed nations, the rate of C-sections is quite high in clinics. For instance, in Bangladesh, less than 60% of the births are known to occur in clinics, and out of them, around 65% are C-sections. Hence, the market is provided with favourable growth opportunities with rising cesarean deliveries.
The global and regional increase in the adoption of cesarean section is attributed to the growing proportion of births taking place in healthcare facilities along with the increase in the cesarean use in these health facilities.
It was further noticed that cesarean section usage was more prevalent in richest countries than poorest in low-income and middle-income countries. Furthermore, high C-section use for observed among individuals with low obstetric risk births, particularly among educated females. For instance, in Brazil and China, the C-section was estimated to be around 1.6 times more frequently performed in a private healthcare setting than in a public healthcare setting. The adoption of C-section will require constant monitoring of the fetus and the new-born after delivery as a part of the C-section planning, further augmenting the market demand in the forecast period.
In the United States, C-sections are the most commonly performed surgeries. The change in policies and clinical information has given rise to better outcomes for the mother and the newborn. The WHO suggested rate for C-section is 10-15%, it has been recommended that annual rate should decline in low-risk females from the current rate of around 27-24%. In the United States, the rate is much higher, around 32%.
Segmentation:
Geographically, North America is projected to hold a significant market share in the forecast period owing to the advanced healthcare facilities for mother and their newborns. Also, the highest health expenditure of the United States is further contributing to surging the market growth in the forecast period. The shift from volume-based care to value-based care is further offering strong market growth prospects in the forecast period. On the other hand, the Asia Pacific region is projected to experience high growth during the forecast period due to rising awareness regarding efficient care during pregnancy and at the time of delivery. Also, significant initiatives for providing efficient healthcare services to the mother and their newborn is further augmenting the market demand in the forecast period.
COVID-19 impact on the fetal & neonatal care equipment market: The novel coronavirus pandemic has affected the global economies. Companies in fetal and neonatal care businesses are trying their level best to monitor the situation closely and are ready to assess any impact on supply and daily operations. Due to lockdown and work-from-home measures companies are working through challenges causing material and capacity issues with some of the suppliers. Hence, the market is projected to experience a slight decline amid COVID-19 due to some level of disruption causing shipment delays to the customers.
The growing fertility tourism will continue to proliferate the market demand during the course of the forecast period.
Fertility treatments, also known as cross border reproductive care (CBRC) are gaining popularity at the global level where people including infertile couples, single, gay, or transgender individuals are seeking effective fertility treatments outside of their home countries. The major reason for the adoption of reproductive treatments abroad includes legal restrictions and the high cost of treatment in their home countries. Also, among other reasons include quality of care, i.e. success rate and long waits, and sociocultural considerations, that play a significant role in choosing fertility treatments abroad. The most common forms of fertility treatments involve in vitro fertilization, intracytoplasmic sperm injection, sperm donation, egg donation, and fertility preservation among others.
Growing infertility among males and females worldwide is one of the major factors driving fertility tourism. In the United States, it has been observed that around 10% of the women that are aged between 15 years of age to 44 years of age are experiencing difficulty in conceiving or staying pregnant. On an international level, it has been estimated that over 8% of the couples are affected by fertility issues. It has further been analyzed that out of all the infertility cases, close to 50% cases are affecting males. Hence, with this, the market is projected to show strong prospects for growth along with a greater demand for reproductive care. Infertility in males is due to specific medical conditions like diabetes, thyroid disorders, genetic disorders, and hormonal imbalances among others. For females, infertility arises due to the adoption of unhealthy living conditions like smoking, active or passive, being obese or overweight, exposure to chemicals, and mental stress among others.
The growing rate of cesarean section is further providing an opportunity for the market to thrive over the forecast period.
It has been noticed on a wide scale that the rate of C-sections is growing at a rapid pace. It has further been observed that the rate of cesarean has exceeded the number of vaginal deliveries in the regions of Southeast Europe, Latin American countries, and China. Even in less-developed nations, the rate of C-sections is quite high in clinics. For instance, in Bangladesh, less than 60% of the births are known to occur in clinics, and out of them, around 65% are C-sections. Hence, the market is provided with favourable growth opportunities with rising cesarean deliveries.
The global and regional increase in the adoption of cesarean section is attributed to the growing proportion of births taking place in healthcare facilities along with the increase in the cesarean use in these health facilities.
It was further noticed that cesarean section usage was more prevalent in richest countries than poorest in low-income and middle-income countries. Furthermore, high C-section use for observed among individuals with low obstetric risk births, particularly among educated females. For instance, in Brazil and China, the C-section was estimated to be around 1.6 times more frequently performed in a private healthcare setting than in a public healthcare setting. The adoption of C-section will require constant monitoring of the fetus and the new-born after delivery as a part of the C-section planning, further augmenting the market demand in the forecast period.
In the United States, C-sections are the most commonly performed surgeries. The change in policies and clinical information has given rise to better outcomes for the mother and the newborn. The WHO suggested rate for C-section is 10-15%, it has been recommended that annual rate should decline in low-risk females from the current rate of around 27-24%. In the United States, the rate is much higher, around 32%.
Segmentation:
- By Type
- Fetal Care
- Neonatal Care
- By Product
- Monitors
- Treatment Equipment
- Diagnostic Equipment
- By End-User
- Hospitals
- Clinics
- Research Centers
- By Geography
- North America
- USA
- Canada
- Mexico
- South America
- Brazil
- Argentina
- Others
- Europe
- UK
- Germany
- France
- Others
- Middle East and Africa
- UAE
- Israel
- Saudi Arabia
- Others
- Asia Pacific
- Japan
- China
- India
- Australia
- Others
1. INTRODUCTION
1.1. Market Definition
1.2. Market Segmentation
2. RESEARCH METHODOLOGY
2.1. Research Data
2.2. Assumptions
3. EXECUTIVE SUMMARY
3.1. Research Highlights
4. MARKET DYNAMICS
4.1. Market Drivers
4.2. Market Restraints
4.3. Market Opportunities
4.4. Porters Five Forces Analysis
4.4.1. Bargaining Power of Suppliers
4.4.2. Bargaining Power of Buyers
4.4.3. Threat of New Entrants
4.4.4. Threat of Substitutes
4.4.5. Competitive Rivalry in the Industry
4.5. Industry Value Chain Analysis
5. FETAL & NEONATAL CARE EQUIPMENT MARKET ANALYSIS, BY TYPE
5.1. Introduction
5.2. Fetal Care
5.3. Neonatal Care
6. FETAL & NEONATAL CARE EQUIPMENT MARKET ANALYSIS, BY PRODUCT
6.1. Introduction
6.2. Monitors
6.3. Treatment Equipment
6.4. Diagnostic Equipment
7. FETAL & NEONATAL CARE EQUIPMENT MARKET ANALYSIS, BY END-USER
7.1. Introduction
7.2. Hospitals
7.3. Clinics
7.4. Research Centers
8. FETAL & NEONATAL CARE EQUIPMENT MARKET ANALYSIS, BY GEOGRAPHY
8.1. Introduction
8.2. North America
8.2.1. North America Fetal & Neonatal Care Equipment Market, By Type
8.2.2. North America Fetal & Neonatal Care Equipment Market, By Product
8.2.3. North America Fetal & Neonatal Care Equipment Market, By End-User
8.2.4. By Country
8.2.4.1. United States
8.2.4.2. Canada
8.2.4.3. Mexico
8.3. South America
8.3.1. South America Fetal & Neonatal Care Equipment Market, By Type
8.3.2. South America Fetal & Neonatal Care Equipment Market, By Product
8.3.3. South America Fetal & Neonatal Care Equipment Market, By End-User
8.3.4. By Country
8.3.4.1. Brazil
8.3.4.2. Argentina
8.3.4.3. Others
8.4. Europe
8.4.1. Europe Fetal & Neonatal Care Equipment Market, By Type
8.4.2. Europe Fetal & Neonatal Care Equipment Market, By Product
8.4.3. Europe Fetal & Neonatal Care Equipment Market, By End-User
8.4.4. By Country
8.4.4.1. UK
8.4.4.2. Germany
8.4.4.3. France
8.4.4.4. Others
8.5. Middle East and Africa
8.5.1. Middle East and Africa Fetal & Neonatal Care Equipment Market, By Type
8.5.2. Middle East and Africa Fetal & Neonatal Care Equipment Market, By Product
8.5.3. Middle East and Africa Fetal & Neonatal Care Equipment Market, By End-User
8.5.4. By Country
8.5.4.1. United Arab Emirates
8.5.4.2. Israel
8.5.4.3. Saudi Arabia
8.5.4.4. Others
8.6. Asia Pacific
8.6.1. Asia Pacific Fetal & Neonatal Care Equipment Market, By Type
8.6.2. Asia Pacific Fetal & Neonatal Care Equipment Market, By Product
8.6.3. Asia Pacific Fetal & Neonatal Care Equipment Market, By End-User
8.6.4. By Country
8.6.4.1. Japan
8.6.4.2. China
8.6.4.3. India
8.6.4.4. Australia
8.6.4.5. Others
9. COMPETITIVE ENVIRONMENT AND ANALYSIS
9.1. Major Players and Strategy Analysis
9.2. Emerging Players and Market Lucrativeness
9.3. Mergers, Acquisitions, Agreements, and Collaborations
9.4. Vendor Competitiveness Matrix
10. COMPANY PROFILES
10.1. Aspect Imaging Ltd.
10.2. General Electric Company
10.3. EMCO Meditek Pvt. Ltd.
10.4. Fisher & Paykel Healthcare Limited
10.5. Masimo Corporation
10.6. Natus Medical Incorporated
10.7. Phoenix Medical Systems (P) Ltd.
10.8. Dr?gerwerk AG & Co. KGaA
10.9. Spacelabs Healthcare (OSI Systems, Inc.)
10.10. Becton, Dickinson and Company
1.1. Market Definition
1.2. Market Segmentation
2. RESEARCH METHODOLOGY
2.1. Research Data
2.2. Assumptions
3. EXECUTIVE SUMMARY
3.1. Research Highlights
4. MARKET DYNAMICS
4.1. Market Drivers
4.2. Market Restraints
4.3. Market Opportunities
4.4. Porters Five Forces Analysis
4.4.1. Bargaining Power of Suppliers
4.4.2. Bargaining Power of Buyers
4.4.3. Threat of New Entrants
4.4.4. Threat of Substitutes
4.4.5. Competitive Rivalry in the Industry
4.5. Industry Value Chain Analysis
5. FETAL & NEONATAL CARE EQUIPMENT MARKET ANALYSIS, BY TYPE
5.1. Introduction
5.2. Fetal Care
5.3. Neonatal Care
6. FETAL & NEONATAL CARE EQUIPMENT MARKET ANALYSIS, BY PRODUCT
6.1. Introduction
6.2. Monitors
6.3. Treatment Equipment
6.4. Diagnostic Equipment
7. FETAL & NEONATAL CARE EQUIPMENT MARKET ANALYSIS, BY END-USER
7.1. Introduction
7.2. Hospitals
7.3. Clinics
7.4. Research Centers
8. FETAL & NEONATAL CARE EQUIPMENT MARKET ANALYSIS, BY GEOGRAPHY
8.1. Introduction
8.2. North America
8.2.1. North America Fetal & Neonatal Care Equipment Market, By Type
8.2.2. North America Fetal & Neonatal Care Equipment Market, By Product
8.2.3. North America Fetal & Neonatal Care Equipment Market, By End-User
8.2.4. By Country
8.2.4.1. United States
8.2.4.2. Canada
8.2.4.3. Mexico
8.3. South America
8.3.1. South America Fetal & Neonatal Care Equipment Market, By Type
8.3.2. South America Fetal & Neonatal Care Equipment Market, By Product
8.3.3. South America Fetal & Neonatal Care Equipment Market, By End-User
8.3.4. By Country
8.3.4.1. Brazil
8.3.4.2. Argentina
8.3.4.3. Others
8.4. Europe
8.4.1. Europe Fetal & Neonatal Care Equipment Market, By Type
8.4.2. Europe Fetal & Neonatal Care Equipment Market, By Product
8.4.3. Europe Fetal & Neonatal Care Equipment Market, By End-User
8.4.4. By Country
8.4.4.1. UK
8.4.4.2. Germany
8.4.4.3. France
8.4.4.4. Others
8.5. Middle East and Africa
8.5.1. Middle East and Africa Fetal & Neonatal Care Equipment Market, By Type
8.5.2. Middle East and Africa Fetal & Neonatal Care Equipment Market, By Product
8.5.3. Middle East and Africa Fetal & Neonatal Care Equipment Market, By End-User
8.5.4. By Country
8.5.4.1. United Arab Emirates
8.5.4.2. Israel
8.5.4.3. Saudi Arabia
8.5.4.4. Others
8.6. Asia Pacific
8.6.1. Asia Pacific Fetal & Neonatal Care Equipment Market, By Type
8.6.2. Asia Pacific Fetal & Neonatal Care Equipment Market, By Product
8.6.3. Asia Pacific Fetal & Neonatal Care Equipment Market, By End-User
8.6.4. By Country
8.6.4.1. Japan
8.6.4.2. China
8.6.4.3. India
8.6.4.4. Australia
8.6.4.5. Others
9. COMPETITIVE ENVIRONMENT AND ANALYSIS
9.1. Major Players and Strategy Analysis
9.2. Emerging Players and Market Lucrativeness
9.3. Mergers, Acquisitions, Agreements, and Collaborations
9.4. Vendor Competitiveness Matrix
10. COMPANY PROFILES
10.1. Aspect Imaging Ltd.
10.2. General Electric Company
10.3. EMCO Meditek Pvt. Ltd.
10.4. Fisher & Paykel Healthcare Limited
10.5. Masimo Corporation
10.6. Natus Medical Incorporated
10.7. Phoenix Medical Systems (P) Ltd.
10.8. Dr?gerwerk AG & Co. KGaA
10.9. Spacelabs Healthcare (OSI Systems, Inc.)
10.10. Becton, Dickinson and Company
